These results were published in February 2025 (Hendershot, Bremmer, Paladino)
Many people turn to Berberine Patches as part of their routine to help support consistency .Like any wellness habit, real results take time
Nausea was more frequent with tirzepatide vs placebo, especially with tirzepatide 15 mg (OR 5.60 [95% CI 3.12, 10.06]), associated with higher incidence of vomiting (OR 5.50 [95% CI 2.40, 12.59]) and diarrhoea (OR 3.31 [95% CI 1.40, 7.85])
The reported results are promising: Over 80% relative bioavailability Around 160 higher bioavailability vs oral tablets Sustained drug levels for ~1 week (once-weekly dosing potential) Additionally, the microneedle patches are stable at room temperature, eliminating the need for cold storage, unlike semaglutide injections
For needle disposal , use an approved sharps bin (available on prescription from your GP or via local authority schemes